Kallyope Competitors and Similar CompaniesClear all
Kallyope's competitors and similar companies include Palleon Pharmaceuticals and LyGenesis.
 Palleon Pharmaceuticals Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer. |  LyGenesis LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. | ||
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations New York, US HQ | Locations Waltham, US HQ | Locations Pittsburgh, US HQ Pittsburgh, US |
Employees | Employees 70 | Employees 25 | Employees 7 |
Funding | |||
Latest funding round | Latest funding round $ 112m (about 6 years ago) | Latest funding round $ 100m (over 5 years ago) | Latest funding round $ 4m (over 6 years ago) |
Total funding raised | Total funding raised $ 243m | Total funding raised $ 147.6m | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Palleon Pharmaceuticals
HQ
Waltham, US
Employees
25
Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer.
View companyLyGenesis
HQ
Pittsburgh, US
Employees
7
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
View company